Vasodilator therapy and ocular diseases
Verin, P.
Bordeaux Medical 3(10): 2509-2510
1970
ISSN/ISBN: 0021-7867 PMID: 4249252 Document Number: 24226
Document emailed within 1 workday
Related Documents
Teodorescu, C.; Teodorescu, I.; Raneti, C.; Dumitrica, D.M.; Stefan, C. 2008: The antitoxoplasma gondii antibodies incidence to the different ocular diseases patients cases of human ocular toxoplasmosis infections in Romania Oftalmologia 52(4): 88-94Kratochvílovà, B.; Profant, O.; Astl, J.ír.; Holý, R. 2016: Our experience in the treatment of idiopathic sensorineural hearing loss (ISNHL): Effect of combination therapy with HBO₂ and vasodilator infusion therapy Undersea and Hyperbaric Medicine: Journal of the Undersea and Hyperbaric Medical Society Inc 43(7): 771-780
Sasayama, S. 1981: Afterload reduction and vasodilator therapy Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 78(3): 127-137
Just, H.; Drexler, H.; Holubarsch, C. 1988: Therapy of heart failure with vasodilator agents Zeitschrift für Kardiologie 77(Suppl 5): 97-101
Mason, D.T.; Awan, N.A.; Demaria, A.N.; Lee, G.; Joye, J.A.; Amsterdam, E.A. 1979: Vasodilator therapy for chronic heart failure Comprehensive Therapy 5(7): 6-14
Katila, M.; Luomanmäki, K. 1980: Vasodilator therapy in congestive heart failure Duodecim; Laaketieteellinen Aikakauskirja 96(5): 430-443
Ito, T.; Matsumoto, S.; Ito, Y. 1978: Chronic heart failure and vasodilator therapy Nihon Rinsho. Japanese Journal of Clinical Medicine 36(11): 3565-3572
Bower, P.J. 1982: Vasodilator therapy in congestive heart failure Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 134(2): 36-39
Hager, W.D. 1977: Vasodilator therapy in coronary artery disease. Part IIi Arizona Medicine 34(8): 565-567
Class, J.J.; Bareiss, P.; Pasquali, J.L.; Meyer, R.; Weryha, A.; Storck, D.; Warter, J. 1978: Intravenous nitroglycerin as vasodilator therapy in acute myocardial infarction La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 54(29-32): 919-924
Williams, R.A.; Wilson, S.E. 1980: Radioxenon washout for evaluation of vasodilator therapy in mesenteric ischemia American Journal of Gastroenterology 73(5): 408-413
Groden, D.L. 1993: Vasodilator therapy for congestive heart failure. Lessons from mortality trials Archives of Internal Medicine 153(4): 445-454
Ausayakhun, S.; Louthrenoo, W.; Aupapong, S. 2002: Ocular diseases in patients with rheumatic diseases Journal of the Medical Association of Thailand 85(8): 855-862
Artese, D.; Albani, A.; Di Tomasso, E. 1983: Vasodilator drugs in the therapy of chronic congestive heart failure. Clinico-case contribution Minerva Medica 74(13): 715-722
Miller, D.C.; Stinson, E.B.; Oyer, P.E.; Derby, G.C.; Reitz, B.A.; Shumway, N.E. 1980: Postoperative enhancement of left ventricular performance by combined inotropic-vasodilator therapy with preload control Surgery 88(1): 108-117
Mauri, F.; Gronda, E.; Bossi, M.; Rovelli, F. 1980: Vasodilator therapy of congestive heart failure: comparison of hemodynamic effects after administration of nitroprusside I.v. and oral prazosin Giornale Italiano di Cardiologia 10(4): 414-423
Kersting, F.; Samosny, G.; Kasper, W.; Schuster, H.P. 1981: Vasodilator therapy with alpha-receptor blockaders. Acute and chronic effect of prazosin and phentolamine in congestive heart failure Die Medizinische Welt 32(26): 1040-1045
Francoual, M.; Nitenberg, A. 1980: Alteration in left ventricular function induced by dihydralazine in severe chronic congestive heart failure: limits of vasodilator therapy? La Nouvelle Presse Medicale 9(19): 1384
Mochizuki, M. 1992: Immunotherapy in ocular diseases Nippon Ganka Gakkai Zasshi 96(12): 1608-1634
Matsuo, N. 1979: Ocular manifestations in the rheumatic diseases Ryumachi 19(4): 370-378